Application of electrochemical biosensors in colorectal cancer research
DOI:
https://doi.org/10.53797/fphj.v3i2.8.2024Keywords:
Electrochemical biosensors, Colorectal cancer, ApplicationsAbstract
Malignant tumors are one of the diseases that seriously threaten human health, among which colorectal cancer is one of the common malignant tumors with high morbidity and high mortality. Early diagnosis and treatment is the main way to reduce the mortality of colorectal cancer, so the accurate detection of colorectal cancer-related substances has important clinical significance in recent years. With the rapid development of electrochemical biosensors and nanomaterials, electrochemical sensors based on nanomaterials can realize the detection of tumor-related indicators, which has the advantages of high sensitivity and strong specificity.
References
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians, 71(3), 209-249.
Xi, Y., & Xu, P. (2021). Global colorectal cancer burden in 2020 and projections to 2040. Translational oncology, 14(10), 101174.
Simon, K. (2016). Colorectal cancer development and advances in screening. Clinical interventions in aging, 967-976.
Hazewinkel, Y., & Dekker, E. (2011). Colonoscopy: basic principles and novel techniques. Nature reviews Gastroenterology & hepatology, 8(10), 554-564.
Kuipers, E. J., Rösch, T., & Bretthauer, M. (2013). Colorectal cancer screening—optimizing current strategies and new directions. Nature reviews Clinical oncology, 10(3), 130-142.
Hoshino, N., Sakamoto, T., Hida, K., & Sakai, Y. (2019). Diagnostic accuracy of computed tomography colonography for tumor depth in colorectal cancer: A systematic review and meta-analysis. Surgical Oncology, 30, 126-130.
Arya, S. K., & Estrela, P. (2018). Recent advances in enhancement strategies for electrochemical ELISA-based immunoassays for cancer biomarker detection. Sensors, 18(7), 2010.
Robinson, K. J., Hazon, N., Lonergan, M., & Pomeroy, P. P. (2014). Validation of an enzyme-linked immunoassay (ELISA) for plasma oxytocin in a novel mammal species reveals potential errors induced by sampling procedure. Journal of neuroscience methods, 226, 73-79.
Howat, W. J., Lewis, A., Jones, P., Kampf, C., Pontén, F., van der Loos, C. M., ... & Warford, A. (2014). Antibody validation of immunohistochemistry for biomarker discovery: recommendations of a consortium of academic and pharmaceutical based histopathology researchers. Methods, 70(1), 34-38.
Rizk, E. M., Gartrell, R. D., Barker, L. W., Esancy, C. L., Finkel, G. G., Bordbar, D. D., & Saenger, Y. M. (2019). Prognostic and predictive immunohistochemistry-based biomarkers in cancer and immunotherapy. Hematology/Oncology Clinics, 33(2), 291-299.
Fourkala, E. O., Blyuss, O., Field, H., Gunu, R., Ryan, A., Barth, J., ... & Menon, U. (2016). Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS). Steroids, 110, 62-69.
Yang, X., Zhao, Y., Sun, L., Qi, H., Gao, Q., & Zhang, C. (2018). Electrogenerated chemiluminescence biosensor array for the detection of multiple AMI biomarkers. Sensors and Actuators B: Chemical, 257, 60-67.
Liu, J., Zhao, J., Li, S., Zhang, L., Huang, Y., & Zhao, S. (2017). A novel microchip electrophoresis-based chemiluminescence immunoassay for the detection of alpha-fetoprotein in human serum. Talanta, 165, 107-111.
Mehta, P. K., Raj, A., Singh, N. P., & Khuller, G. K. (2014). Detection of potential microbial antigens by immuno-PCR (PCR-amplified immunoassay). Journal of medical microbiology, 63(5), 627-641.
Wang, J. (2005). Nanomaterial-based electrochemical biosensors. Analyst, 130(4), 421-426.
Filik, H., & Avan, A. A. (2019). Nanostructures for nonlabeled and labeled electrochemical immunosensors: Simultaneous electrochemical detection of cancer markers: A review. Talanta, 205, 120153.
Hammond, J. L., Formisano, N., Estrela, P., Carrara, S., & Tkac, J. (2016). Electrochemical biosensors and nanobiosensors. Essays in biochemistry, 60(1), 69-80.
Ronkainen, N. J., Halsall, H. B., & Heineman, W. R. (2010). Electrochemical biosensors. Chemical Society Reviews, 39(5), 1747-1763.
Rashid, J. I. A., & Yusof, N. A. (2017). The strategies of DNA immobilization and hybridization detection mechanism in the construction of electrochemical DNA sensor: A review. Sensing and bio-sensing research, 16, 19-31.
Maqbool, R., & Hussain, M. U. (2014). MicroRNAs and human diseases: diagnostic and therapeutic potential. Cell and tissue research, 358, 1-15.
Shirafkan, N., Mansoori, B., Mohammadi, A., Shomali, N., Ghasbi, M., & Baradaran, B. (2018). MicroRNAs as novel biomarkers for colorectal cancer: New outlooks. Biomedicine & Pharmacotherapy, 97, 1319-1330.
Ng, E. K., Chong, W. W., Jin, H., Lam, E. K., Shin, V. Y., Yu, J., ... & Sung, J. J. (2009). Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut, 58(10), 1375-1381.
Li, T., Leong, M. H., Harms, B., Kennedy, G., & Chen, L. (2013). MicroRNA-21 as a potential colon and rectal cancer biomarker. World journal of gastroenterology: WJG, 19(34), 5615.
Jang, W., Kim, H. S., Alam, K., Ji, M. K., Cho, H. S., & Lim, H. P. (2021). Direct-deposited graphene oxide on dental implants for antimicrobial activities and osteogenesis. International Journal of Nanomedicine, 5745-5754.
Bridgewater, J. A., Pugh, S. A., Maishman, T., Eminton, Z., Mellor, J., Whitehead, A., ... & Potter, V. (2020). Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial. The lancet oncology, 21(3), 398-411.
Bourhis, J., Stein, A., de Boer, J. P., Van Den Eynde, M., Gold, K. A., Stintzing, S., ... & Ciardiello, F. (2021). Avelumab and cetuximab as a therapeutic combination: An overview of scientific rationale and current clinical trials in cancer. Cancer treatment reviews, 97, 102172.
Li, Y., Chen, X., Li, W., Ye, Y., Du, X., Sun, S., ... & Zhang, H. (2021). Combination of anti-EGFR and anti-VEGF drugs for the treatment of previously treated metastatic colorectal cancer: a case report and literature review. Frontiers in Oncology, 11, 684309.
Cruz-Pacheco, A. F., Echeverri, D., & Orozco, J. (2024). Role of electrochemical nanobiosensors in colorectal cancer precision medicine. TrAC Trends in Analytical Chemistry, 170, 117467.
Duffy, M. J. (2001). Carcinoembryonic antigen as a marker for colorectal cancer: is it clinically useful?. Clinical chemistry, 47(4), 624-630. Lișcu, H. D., Verga, N., Atasiei, D. I., Badiu, D. C., Dumitru, A. V., Ultimescu, F., ... & Ionescu, A. I. (2024). Biomarkers in Colorectal Cancer: Actual and Future Perspectives. International Journal of Molecular Sciences, 25(21), 11535.
Sadik, O. A., Mwilu, S. K., & Aluoch, A. (2010). Smart electrochemical biosensors: From advanced materials to ultrasensitive devices. Electrochimica Acta, 55(14), 4287-4295.
Grieshaber, D., MacKenzie, R., Vörös, J., & Reimhult, E. (2008). Electrochemical biosensors-sensor principles and architectures. Sensors, 8(3), 1400-1458.
Zhang, W., Xiao, G., Chen, J., Wang, L., Hu, Q., Wu, J., ... & Xu, C. (2021). Electrochemical biosensors for measurement of colorectal cancer biomarkers. Analytical and Bioanalytical Chemistry, 413, 2407-2428.
Siegel, R. L., Miller, K. D., & Jemal, A. (2018). Cancer statistics, 2018. CA: a cancer journal for clinicians, 68(1), 7-30.
Zheng, R., Zhang, S., Zeng, H., Wang, S., Sun, K., Chen, R., ... & He, J. (2022). Cancer incidence and mortality in China, 2016. Journal of the National Cancer Center, 2(1), 1-9.
Benson, A. B., Venook, A. P., Al-Hawary, M. M., Arain, M. A., Chen, Y. J., Ciombor, K. K., ... & Gurski, L. A. (2021). Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network, 19(3), 329-359.
Quinchia, J., Echeverri, D., Cruz-Pacheco, A. F., Maldonado, M. E., & Orozco, J. (2020). Electrochemical biosensors for determination of colorectal tumor biomarkers. Micromachines, 11(4), 411.
Yang, G., Xiao, Z., Tang, C., Deng, Y., Huang, H., & He, Z. (2019). Recent advances in biosensor for detection of lung cancer biomarkers. Biosensors and Bioelectronics, 141, 111416.
Duffy, M. J. (2007). Role of tumor markers in patients with solid cancers: a critical review. European journal of internal medicine, 18(3), 175-184.
Khan, R., Radoi, A., Rashid, S., Hayat, A., Vasilescu, A., & Andreescu, S. (2021). Two-dimensional nanostructures for electrochemical biosensor. Sensors, 21(10), 3369.
Guo, L., Zhao, Y., Huang, Q., Huang, J., Tao, Y., Chen, J., ... & Liu, H. (2024). Electrochemical protein biosensors for disease marker detection: progress and opportunities. Microsystems & Nanoengineering, 10(1), 65.
Zhong, M. E., Chen, Y., Xiao, Y., Xu, L., Zhang, G., Lu, J., ... & Wu, B. (2019). Serum extracellular vesicles contain SPARC and LRG1 as biomarkers of colon cancer and differ by tumour primary location. EBioMedicine, 50, 211-223.
Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. cell, 144(5), 646-674.
Bukowski, K., Kciuk, M., & Kontek, R. (2020). Mechanisms of multidrug resistance in cancer chemotherapy. International journal of molecular sciences, 21(9), 3233.
Van Cutsem, E., Köhne, C. H., Hitre, E., Zaluski, J., Chang Chien, C. R., Makhson, A., ... & Rougier, P. (2009). Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. New England Journal of Medicine, 360(14), 1408-1417.
Duffy, M. J. (2012). Tumor markers in clinical practice: a review focusing on common solid cancers. Medical Principles and Practice, 22(1), 4-11.
Lu, Y., Lin, B., & Li, M. (2024). The role of alpha-fetoprotein in the tumor microenvironment of hepatocellular carcinoma. Frontiers in Oncology, 14, 1363695.
Abolhasan, R., Khalilzadeh, B., Yousefi, H., Samemaleki, S., Chakari-Khiavi, F., Ghorbani, F., ... & AghebatiMaleki, L. (2021). Ultrasensitive and label free electrochemical immunosensor for detection of ROR1 as an oncofetal biomarker using gold nanoparticles assisted LDH/rGO nanocomposite. Scientific Reports, 11(1), 14921.
Lowrance, W., Dreicer, R., Jarrard, D. F., Scarpato, K. R., Kim, S. K., Kirkby, E., ... & Cookson, M. S. (2023). Updates to advanced prostate cancer: AUA/SUO guideline (2023). The Journal of Urology, 209(6), 1082-1090.
Overall, C. M., & Kleifeld, O. (2006). Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nature Reviews Cancer, 6(3), 227-239.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Min Liu, Guang Tian, Yangrong Long, Xianxian Zhang, Longyan Ran, Geetha Nalairndran, Sangita Biswas
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
